Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane): clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
3
Conditions studied
49
US states with sites
5
Countries
Phase breakdown
Phase 3 2
Conditions being studied
| Condition | Trials |
|---|---|
| Breast Cancer | 2 |
| Adjuvant Therapy | 1 |
| Stage I Breast Cancer | 1 |
Recruiting trials involving Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane)
- CDK4/6 Inhibitors Combined With Standard Adjuvant Endocrine Therapy in High-Risk, HR+/HER2+ Early Breast Cancer Patients(CHESS)
- De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Common questions
How many recruiting trials involve Endocrine Therapy (Tamoxifen, Anastrozol, Letrozole, Exemestane)?
2 recruiting trials across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.